skip to content »

Structural and Computational Biology and Molecular Biophysics

Houston, Texas

A BCM research lab.
Structural and Computational Biology & Molecular Biophysics
not shown on screen

Mauro Ferrari, Ph.D.

Mauro Ferrari, Ph.D.President and CEO

Ernest Cockrell Jr. Distinguished Endowed Chair

The Methodist Hospital Research Institute

President, The Alliance for NanoHealth

Education:

Dottore Mathematics, Universita’ di Padova, Italy (1985)
M.S. Mechanical Engineering, University of California, Berkeley (1987)
Ph.D. Mechanical Engineering, University of California, Berkeley (1989)

Research Interests:

  • Nanomedicine for oncology, traumatic injury, cardiovascular disease, infectious pathologies, and diabetes
  • Nanofluidics
  • Biomedical Microtechnology (BioMEMS)
  • Drug delivery
  • Proteomics and peptidomics for early detection and therapeutic monitoring
  • Cell transplantation, regenerative medicine, and tissue engineering
  • Biosensors and bioseparation technology
  • Multiscale discrete/continuum mechanics and biomechanics
  • Bioethics

Major Areas of Research

Nanotechnology, Biomechanics, Microtechnology, Bioengineering, Biomaterials

Selected Publications:

  • Ferrati S, McConnell KI, Mack AC, Sirisaengtaksin N, Diaz R, Bean AJ, Ferrari M and Serda RE. Cellular communication via nanoparticle-transporting biovesicles. Nanomedicine (Lond), [Epub ahead of print] (2013). PubMed
  • Bansal SS, Celia C, Ferrati S, Zabre E, Ferrari M, Palapattu G and Grattoni A. Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations. Curr Drug Targets, [Epub ahead of print] (2013). PubMed
  • Martinez JO, Boada C, Yazdi IK, Evangelopoulos M, Browns BS, Liu X, Ferrari M and Tasciotti E. Mesoporous silicon: short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors (small 9-10/2013). Small, 9(9-10):1721 (2013). PubMed
  • Shen H, Mittal V, Ferrari M and Chang J. Delivery of gene silencing agents for breast cancer therapy. Breast Cancer Res, 15(3):205 (2013). PubMed
  • Adriani G, de Tullio MD, Ferrari M, Hussain F, Pascazio G, Liu X and Decuzzi P. The preferential targeting of the diseased microvasculature by disk-like particles. Biomaterials, 33(22):5504-13 (2012). PubMed
  • Shen H, Sun T and Ferrari M. Nanovector delivery of SiRNA for cancer therapy. Cancer Gene Ther, 19(6):367-73 (2012). PubMed
  • Fan J, Gallagher JW, Wu HJ, Landry MG, Sakamoto J, Ferrari M and Hu Y. Low molecular weight protein enrichment on mesoporous silica thin films for biomarker discovery. J Vis Exp., 62 (2012). PubMed

    For more publications, see listing on PubMed.

Contact Information:

Address: The Methodist Hospital Research Institute
6670 Bertner St., M.S. R2-216
Houston, TX 77030
Phone: 713-441-7250
Fax: 713-441-8235
E-mail: mferrari@tmhs.org
www.tmhri.org

Additional Links:

The Alliance for NanoHealth

Discovery Health: Nanotechnology-Enabled Medicine

E-mail this page to a friend